NOTE 27: BENITEC BIOPHARMA LIMITED PARENT COMPANY INFORMATION Contingent liabilities Capital commitments Significant accounting policies The parent entity had no contingent liabilities as at 30 June 2014 (2013: nil), other than the contingent liabilities described in note 22.  The parent entity has no capital commitments as at 30 June 2014 (2013: nil). The accounting policies of the parent are consistent with those of the consolidated entity (Note 1) Benitec Biopharma Ltd  Annual Report 2014 Page 41 Parent Entity 2014 2013 $ $ ASSETS Current assets  34,386,167 1,478,422 Non-current assets  181,547  48,999 TOTAL ASSETS  34,567,714 1,527,421 LIABILITIES Current liabilities  1,311,608 1,165,652 Non-current liabilities  -  - TOTAL LIABILITIES  1,311,608 1,165,652 NET ASSETS  33,256,106 361,769 EQUITY Contributed equity  129,185,675  89,609,248 Share based payments reserve  2,096,818  1,591,702 Accumulated losses  (98,026,387)  (90,839,181) TOTAL EQUITY  33,256,106  361,769 FINANCIAL PERFORMANCE Loss for the year  (7,037,206)  (4,885,852) Other comprehensive income  -  - TOTAL COMPREHENSIVE INCOME  (7,037,206)  (4,885,852) Notes to the Consolidated Financial Statements for the Year Ended 30 June 2014